Imipramine binding to platelets of children with attention deficit disorder with hyperactivity

Biological Psychiatry

Volumn 23, Issue 5, 1988, Pages 491-496

  Weizman, Abraham ^a   Bernhout, Edna ^a   Weitz, Raphael ^a   Tyano, Sam ^a   Rehavi, Moshe ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPRAMINE; METHYLPHENIDATE;

ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; HUMAN; HYPERACTIVITY; PRIORITY JOURNAL; THROMBOCYTE;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BLOOD PLATELETS; CHILD; HUMAN; IMIPRAMINE; MALE; METHYLPHENIDATE; RECEPTORS, NEUROTRANSMITTER; RECEPTORS, SEROTONIN; SUPPORT, NON-U.S. GOV'T;

EID: 0023851984     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(88)90021-2     Document Type: Article

References (38)

1. Hyperactive children treated with stimulants
2. Serotonin uptake and imipramine binding in blood platelets and brain of Fawn-Hooded and Sprague-Dawley rats
3. The effect of pyridoxine hydrochloride on blood serotonin and pyridoxal phosphate contents in hyperactive children
4. Possible role of 5-hydroxytryptamine in minimal brain dysfunction
5. Imipramine binding: Its relationship with serotonin uptake and depression
6. 3H]imipramine
7. Serotonin concentrations in whole blood of hyperactive children
8. A preliminary study of the effect of pyridoxine administration in a subgroup of hyperkinetic children: A doubleblind crossover
9. Serotonin “agonists” in an animal model of attention deficit disorder (ADD)
10. Rating scales for use in drug studies with children
11. Fenfluramine treatment of childhood attention deficit disorder with hyperactivity: A preliminary report
12. 3H]imipramine binding in platelets and cerebral cortex of Fawn-Hood rats
13. Plasma free and total tryptophan, blood serotonin, and the hyperactivity syndrome: No evidence for the serotonin deficiency hypothesis
14. Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children
15. Blood serotonin levels in the attention-deficit disorder
16. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine
17. Effects of serotonergic agonists and antagonists on the locomotor activity of neonatal rats
18. The effects of fenfluramine and fluoxitine on the acquisition of a conditioned avoidance response on rats
19. The effects of fenfluramine on suicidal behavior
20. Amino acid supplementation as therapy for attention deficit disorder
21. Central serotonin neurones in avoidance learning Interactions with noradrenaline and dopamine neurones
22. Psychiatric interviews suitable for use in research with children and adolescents
23. 3]imipramine on human platelets
24. Methylphenidate and children with attention deficit disorder: Dose effects on classroom academic and social behavior
25. Platelet serotonin of hyperactive school age boys
26. New drug trials in attention deficit disorder
27. High affinity binding sites for tricyclic antidepressants in brain and platelets
28. 3H]imipramine binding in platelets of children and adolescents with major affective disorders
29. Fenfluramine treatment of autism: UCLA collaborative study of 81 patients at nine medical centers
30. Studies of various amphetamine and clonidine on body temperature and brain 5-hydroxy-tryptamine metabolism in rats
31. CSF monoamine metabolites in children with minimal brain dysfunction—Evidence for alteration of brain dopamine
32. The biochemical basis of minimal brain dysfunction
33. Evidence that serotonin mediates some behavioral effects of amphetamine
34. The human platelet: A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders
35. 3H]imipramine binding in platelets of enuretic children and adolescents
36. Urinary monoamine metabolites in children with minimal brain dysfunction
37. Stimulants, urinary catecholamines, and indoleamines in hyperactivity: A comparison of methylphenidate and dextroamphetamine
38. Treatment of hyperactive children with monamine oxidase inhibitors: Clinical efficacy